Answer
Pegasys (peginterferon alfa-2a) may be used during pregnancy only if the potential benefit justifies the potential risk to the foetus; combination treatment with ribavirin is contraindicated in pregnant women.
Sources for this answer
- Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringepharmaand GmbH · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked